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Evaluation of testicular glycogen storage, 
FGF21 and LDH expression and physiological 
parameters of sperm in hyperglycemic rats 
treated with hydroalcoholic extract of Securigera 
Securidaca seeds, and Glibenclamide
Mohammad Babaei1†, Shahin Alizadeh‑Fanalou2†, Alireza Nourian3, Sahar Yarahmadi2, Navid Farahmandian2, 
Mohsen Nabi‑Afjadi4, Iraj Alipourfard5 and Elham Bahreini2*  
Abstract 
Structural and physiological changes in sperm and semen parameters reduce fertility in diabetic patients. Securigera 
Securidaca (S. Securidaca) seed is a herbal medicine with hypoglycemic, antioxidant, and anti‑hypertensive effects. The 
question now is whether this herbal medicine improves fertility in diabetic males. The study aimed to evaluate the 
effects of hydroalcoholic extract of S. Securidaca seeds (HESS), glibenclamide and a combination of both on fertil‑
ity in hyperglycemic rats by comparing histological and some biochemical changes in testicular tissue and sperm 
parameters. The treatment protocol included administration of three doses of HESS and one dose of glibenclamide, 
as well as treatment with both in diabetic Wistar diabetic rats and comparison of the results with untrated groups. The 
quality of the testicular tissue as well as histometric parameters and spermatogenesis indices were evaluated during 
histopathological examination. Epididymal sperm analysis including sperm motility, viability, abnormalities, maturity, 
and chromatin structure were studied. The effect of HESS on the expression of LDH and FGF21 genes and tissue levels 
of glycogen, lactate, and total antioxidant capacity in testicular tissue was investigated and compared with gliben‑
clamide. HESS improved sperm parameters in diabetic rats but showed little restorative effect on damaged testicular 
tissue. In this regard, glibenclamide was more effective than the highest dose of HESS and its combination with HESS 
enhanced its effectiveness so that histological tissue characteristics and sperm parameters were were comparable to 
those of healthy rats. The expression level of testicular FGF21 gene increased in diabetic rats, which intensified after 
treatment with HESS as well as glibenclamide. The combination of HESS and glibenclamide restored the expression 
level of testicular LDH gene, as well as tissue storage of glycogen, lactate and LDH activity, and serum testosterone to 
the levels near healthy control. S. Securidaca seeds can be considered as an effective supplement in combination with 
hypoglycemic drugs to prevent infertility complications in diabetes.
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Introduction
A proven feature of diabetes mellitus (DM) is the reduc-
tion in male fertility, both in terms of semen param-
eters and sperm structures [1, 2]. These effects are 
described as devastating changes in spermatogenesis 
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and testicular tissue through pre-testicular, testicular, 
and post-testicular mechanisms. Pre-testicular failure 
mostly occurs in the hypothalamic-pituitary–gonadal 
axis and results in testosterone deficiency [3, 4]. The 
testicular mechanism induced by elevated oxidative 
stress and non-enzymatic glycation products (AGEs) 
[5], sperm DNA fragmentation [6], and mitochondrial 
bioenergy alteration [7]. Moreover, the most common 
post-testicular cause is infection and inflammation of 
the male accessory gland [8, 9]. The process of spermat-
ogenesis is strictly regulated by the function of Sertoli 
cells, which maintain the division of germ cells and pro-
vide supporting factors such as hormones, various pro-, 
and anti-apoptotic agents, and energetic substrates. 
Sertoli cells metabolize glucose to pyruvate through 
cytoplasmic glycolysis, immediately reduce it to lac-
tate by lactate dehydrogenase (LDH), and export it to 
the intratubular fluid by monocarboxylate transporter 4 
(MCT4). Lactate is the preferred energy source for the 
development of postmeiotic germ cells, especially sper-
matocytes and spermatids. The released lactate is taken 
up by germ cells via MCTs and converted to pyruvate, 
while the resulting NADH can modify the redox status 
of germ cells. This metabolic pattern is referred to as 
“Warburg-like metabolism” and is frequently observed 
in cancer cells [10–12]. Galardo et al. [13] showed that 
lactate increased mRNA levels of MCT2 and LDH-C, 
but not MCT4 and LDH-A.
MCTs, are a family of proton-linked plasma membrane 
transporters that carry monocarboxylates across biologi-
cal membranes. MCT2 is a transporter predominantly 
expressed in germ cells with a high affinity for lactate 
[14], while MCT4 is with lower affinity one and respon-
sible for sending out lactate of highly active glycolytic 
cells such as Sertoli cells [15]. LDH isozymes are tetram-
ers composed from the two most common subunits, of 
LDH-M and LDH-H protein, that are encoded by the 
LDHA and LDHB genes, respectively. However, there are 
two more mammalian LDH subunits that can be included 
in LDH tetramers: LDHC and LDHBx. LDH-C is a tes-
tes-specific LDH protein, that is encoded by the LDHC 
gene. It is found only in germ cells and preferentially con-
verts lactate to pyruvate. In contrast, LDH-A preferen-
tially converts pyruvate to lactate and is more likely to be 
expressed in Sertoli cells, which produce large amounts 
of lactate [16, 17]. Since lactate is the primary source of 
ATP and sperm activity, any failure of glucose uptake, 
lactate transport, and the LDH-C gene can disrupt sperm 
motility patterns and male fertility [16]. The presence of 
glycogen and enzymes involved in its metabolism in tes-
ticular tissue has already been reported. In abnormal suf-
ficiency of insulin and glucose concentration, testicular 
glycogen is an alternative fuel [18] which is documented 
by increase in uridine diphosphate (UDP) glucose as the 
glycosyl donor for glycogen synthesis [19].
Fibroblast growth factor 21 (FGF21), as an important 
metabolic regulator produced mainly in liver as well as 
in skeletal muscle, adipose tissue and to a lesser extent in 
in testis, plays a key role in glucose homeostasis, insulin 
sensitivity, and ketogenesis, as well as normal spermato-
genesis [20]. FGF21 maintains normal germ cell apop-
tosis and spermatogenesis homeostasis by suppressing 
p53 activation via MDM2 (human murine double min-
ute 2) through AKT, especially AKT1 [21]. Although 
high blood sugar and oxidative stress products stimulate 
FGF21 expression, deficiency of FGF21 enhances germ 
cell apoptosis due to diabetes -induced oxidative damage 
[20].
The plant S. securidaca (L.) Degen & Dorfl (Bitter Len-
tils) is widely used as a medicinal plant in traditional Ira-
nian medicine locally known as names Adasol-Molk and 
Gande-Talkhe. Egyptians and Indians used it to treat high 
blood sugar in patients. In support of the chemical analy-
sis, Garani et al. showed the presence of flavonoids, sapo-
nins, tannins and alkaloids in the hydroalcoholic extract 
of S. Securidaca [22]. The further phytochemical analysis 
by Aldal’in et al. showed high content of aromatic deriva-
tives, dodecanedioic acid derivatives and L-ascorbic acid, 
and β-sitosterol and oxygenated hydrocarbons such as, 
Acyl Glucuronides, α-D-glucopyranose, N-butylglycine 
and 1, 3-propanediol in this plant [23]. The plant has been 
used for the treatment of hyperlipidemia, hypertension 
and as also antioxidant. The hydroalcoholic extract of S. 
securidaca seeds (HESS) has been shown to have facilita-
tive effects as an adjunct to classic diabetes medications 
such as glibenclamide [24, 25]. In the current study, the 
impact of HESS, glibenclamide and the combination of 
both on the testes of the diabetic rat were investigated 
by comparing histological and some biochemical altera-
tions in testicular tissue and changes in sperm parame-
ters. To our knowledge, this is the first study to evaluate 
the effects of HESS and glibenclamide separately and in 
combination on testicular tissue and sperm parameters 
in hyperglycemic male rats.
Materials and methods
The preparation of hydroalcoholic seed extract 
and estimation of total phenolic and flavonoid content
The hydroalcoholic extract of the S. securidaca seed 
(herbarium code of PMP-756) and measurement of 
the total phenolic and flavonoid contents have been 
fully described in the previous article [24]. Briefly, the 
ground  seed was extracted  using 70% ethanol and con-
centrated by  rotary evaporation. According to the 
method described by Singleton and Rossi, Folin Ciocalteu 
reagent and gallic acid were used as standard to measure 
Page 3 of 15Babaei et al. Reprod Biol Endocrinol          (2021) 19:104  
the total phenolic content [26]. In addition, the flavonoid 
content of the extract was determined by the aluminum 
chloride colorimetric method and quercetin was used as 
the standard [27].
Experimental animals
The sample size calculation was done based on the 
resource equation [28]. Forty eight healthy male Wistar 
rats with an average weight of 240 g were obtained from 
Laboratory Animal Center of Iran University of Medical 
Sciences, and kept in a well-ventilated room with free 
access to food and water for one week before the experi-
ments. Animals were randomly allocated to 8 groups of 
6 rats. After isolating 6 mice as a healthy control group 
(without treatment), hyperglycemia was  induced  in the 
rest of the animals by intraperitoneal  injection of Strep-
tozotocin (STZ, 55  mg/kg-BW). A blood sugar level 
of ≥ 200  mg/dL was considered as diabetic. The animal 
work was performed according to the ethical considera-
tions of working with laboratory animals approved by 
the Ministry of Health of Iran and the instructions of the 
laboratory animal care department of Iran University of 
Medical Sciences. (https:// ethics. resea rch. ac. ir/ docs/ Eth-
ics- Lab- Animal- Codes. pdf ).
Experimental design
Three doses of HESS (100, 200, and 400  mg/kg-BW) 
[29] and one dose of glibenclamide (5 mg/kg-BW) were 
considered. The experimental groups were as follows: 
(I) normal (healthy) control (NC), (II) diabetic control 
(DC), (III) to (V) diabetic rats treated with HESS doses of 
100, 200 and 400 mg/kg-BW as E-100, E-200 and E-400 
groups, respectively, (VI) diabetic rats treated with 5 mg/
kg-BW glibenclamide (G) [30], and groups (VII) and 
(VIII) treated with both glibenclamide and HESS (200 
and 400  mg/kg-BW) as G + HESS-200 and G + HESS-
400 groups, respectively. Administration of HESS and 
glibenclamide was carried out by gavage once a day for 
35 days.
Sampling
At the end of the study, the rats were anesthetized with 
chloroform. The blood sample was collected through car-
diac puncture and centrifuged (2000  g, 10  min, 23  °C). 
The resultant serum was separated and stored at -20  °C 
until analysis. Immediately after sacrificing the animals, 
the testes were removed and their size, weight, and 
appearance were evaluated by an experienced person. 
Left testicles were placed in 10% neutral buffered for-
malin for histological evaluation and the right ones were 
used for molecular and biochemical examination. The 
gonadosomatic indices (GSI), as an indicator of gonadal 
development or sexual maturity of an animal, were 
calculated as follows: (testes weight/body weight) × 100 
[31].
Epididymal sperm analysis
The caudal region of the epididymis was cut into small 
segments, which were added to 1 mL human tubal fluid 
(HTF) containing 4  mg bovine serum albumin (BSA). 
The container was then incubated for 10  min at 37 ºC 
with 5% CO2 to let the sperm to swim out of tubules. 
Epididymal spermatozoa were counted by a hemocytom-
eter according to the standard hemocytometric method. 
The epididymal sperm was diluted at 1:20 in HTF solu-
tion, and 10 μL of the suspension was transferred to the 
counting chamber of the hemocytometer. After resting 
for 5 min in a humid chamber for sedimentation of the 
cells and prevention from drying, the spermatozoa were 
counted by a light microscope at 400 × magnification and 
considered as the number of cells per mL.
– The sperm motility was examined using an optical 
microscope at a visual magnification of 400 × . 20 
μL of sperm suspension was placed on a microscope 
slide and a coverslip was placed on it. The quantity 
of sperm motility was evaluated in 10 microscopic 
fields, and was expressed as the percentage of motile 
sperms.
– The sperm viability was determined by Eosin-Y 
(0.05%) [32]. Twenty µL of sperm suspension was 
added into 20 µL Eosin-Y and the mixture was incu-
bated at room temperature for 2 min. Then, the via-
bility of sperm was assessed microscopically (400 ×). 
In this method, the spermatozoa with intact plasma 
membrane are not stained, while the cells with a 
modified plasma membrane turn pink. The viability 
was estimated by the ratio of “unstained /pink sper-
matozoa “and reported as a percentage.
– The sperm abnormalities were evaluated by prepa-
ration of the sperm smears on clean slides. After 
air-drying, the slides were stained by Eosin-Y 
(1%)-Nigrosine (5%). Morphological abnormalities 
such as amorphous, hook-less, bi-cephalic, coiled, 
or abnormal tails and attached cytoplasmic drop-
lets were analyzed using a microscope (400 ×) and 
reported percentage.
– Evaluation of the sperm chromatin structure was 
carried out by the Acridine orange test by slight 
modifications [33], which indicates the extent of 
chromatin denaturation. The air-dried smears of the 
sperm suspension on glass slides were fixed for 2  h 
in methanol-acetic acid (1:3, v/v). The slides were 
stained with Acridine orange solution (19%) in phos-
phate citrate buffer for 5 min, washed with deionized 
water, and visualized by a fluorescence microscope. 
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The spermatozoa with intact chromatin structure 
exhibited a green fluorescence while those with dena-
tured chromatin showed a reddish-orange color.
– The sperm maturity was evaluated by Aniline blue 
staining by slight modifications [34], which differen-
tiates lysine-rich histone proteins in immature and 
arginine/cysteine-rich protamine in mature sperm 
nucleus. The values were reported as a percentage.
Biochemical Assay
The effects of various doses of HESS, alone and in com-
bination with glibenclamide, on body weight, cardiovas-
cular indices and some serum biochemical parameters as 
well as oxidant and antioxidant factors were assessed in 
our previous studies [24, 25]. In this study, serum testos-
terone and testicular tissue concentration of LDH, glyco-
gen and total antioxidant were determined as:
-Testosterone: the circulating levels of testoster-
one were measured using a radioimmunoassay kit 
(Rat Testosterone Kit, Mybiosurce) according to the 
manufacturer instructions. The assay sensitivity was 
0.04 ng/mL.
-Tissue levels of lactate and LDH activity: After 
rinsing with 0.01 M PBS buffer, the right testicles of 
all groups were cut sagittally to right and left halves 
for molecular and biochemical studies, respectively. 
After weighing the samples in cold conditions, the 
testicular tissue washomogenized in 0.1 M cold PBS 
(pH 7.0) containing EDTA using a rotary homog-
enizer. The homogenate was centrifuged at 3000  g 
for 10  min at 4  °C and the supernatant was kept 
at − 80 °C until analyzed.
-Total protein concentrations were determined by 
the Lowry method. Tissue levels of lactate and LDH 
were measured using Rat ELISA Kits (MBS269777, 
MyBioSource, USA) according to the manufacturer’s 
instructions. The levels of lactate and LDH were 
reported as nm/mg-tissue and U/mg- total protein-
tissue (specific activity), respectively.
-Testicular glycogen: The amount of glycogen in tis-
sues was determined by aRat Glycogen (GLY) ELISA 
kit (MBS729293, MyBioSource, USA) and was 
reported as µg/mg-tissue.
-Total tissue antioxidant levels: The total antioxi-
dant level of testicular tissue was measured by ferric 
reducing antioxidant power (FRAP) [35]. The reduc-
tion of  Fe3+ to  Fe2+ by the sample was considered 
as an antioxidant power indicator. In this method, 
the complex between  Fe2+ and tripyridyltriazine 
 (Fe2+-TPTZ) creates a blue color with maximum 
light absorption at 593  nm. The results were com-
pared with the standard curve derived based on a 
serial dilution of  Fe2SO4 (ranging from 100 to 800 
μMol) in 1 mL of FRAP reagent (300 mMol acetate 
buffer, 10 mMol TPTZ/HCl solution, and 20 mMol 
ferric chloride). The values were expressed as µMol 
 Fe2+/g-tissue weight.
Total RNA extraction, cDNA synthesis and Quantitative 
Real-Time PCR (RT-PCR)
The study of gene expression levels of testicular LDH 
and fibroblast growth factor-21 (FGF-21) was per-
formed by Quantitative Real-Time PCR (RT-qPCR) 
technique. About 20–30  mg testicular tissue was fro-
zen in liquid nitrogen and pulverized in a mortar and 
pestle in more liquid nitrogen. The powdered tissue 
was homogenized in TRIzol Reagent and total RNA 
was extracted using Total RNA Extraction kit (cat. no. 
FAPDE050, Yektatajhize, Iran), according to the man-
ufacturer’s protocol. After quantitative and qualita-
tive evaluation of the purified RNA using a Nanodrop 
(ND-1000 spectrophotometer, Yektatajhize, Iran), the 
total RNA was reverse-transcribed into first-strand 
complementary DNA (cDNA) using cDNA Synthesis 
Kit (cat. no. YT4500, Yektatajhize, Iran) according to 
the manufacturer’s instruction. The GAPDH (glycer-
aldehyde 3-phosphate dehydrogenase) gene was used 
as an internal control to quantify the expression of the 
target genes. Two target genes (LDH and FGF-21) and 
GAPDH internal control were amplified with suitable 
primers designed by NCBI primer design (Table 1). The 
synthesized cDNA was subjected to RT-qPCR quanti-
tation using Super SYBR Green qPCR MasterMix (cat. 
no. YT2552, Yektatajhize, Iran) in a 20  μL reaction 
mixture containing RT-PCR Master Mix (10  μL), for-
ward and reverse primers (1 μL), double distilled  H2O 
(6  μL) and cDNA (3  μL). The initial denaturation was 
95  °C for 3 min, 40 cycles of denaturation at 95  °C for 
10 s, annealing at 60 °C for 10 s, elongation at 72 °C for 
30 s, and final elongation at 72 °C for 5 min. The cycle 
Table 1 Primer sequences for RT‑qPCR





GAPDH TCA TCA ACG GCA CAG TCA AGG 
TTC TGC ATG GTG GTG AAG ACG 
60.88
60.88
LDH‑C TTT AGC CTT TTC CTC AGC ACTCC 
AGT CTA GGT TAC AGC CAC TTCC 
60.81
59.17
FGF‑21 TTC GGG ACT GTG GGT CTG TCTC 
TTT GCA GGT GGG CTT CGG TG
62.6
62.1
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threshold (Ct) of amplification was determined and 
normalized by the value of GAPDH. The expression 
fold change was calculated using the  2−ΔΔCt method.
Histopathology
After fixation in neutral buffered formalin, the testicles 
were dehydrated in ascending ethanol concentrations, 
cleared in xylene, and infiltrated and embedded in par-
affin. Then, using a rotary microtome (Leica RM2255, 
Germany), the tissue blocks were sectioned at 5–6  µm, 
stained with hematoxylin and eosin (H&E), and exam-
ined independently by a veterinary pathologist using a 
light microscope (Olympus CX41, Japan) equipped with 
a digital camera (Olympus DP25, Germany).
Spermatogenesis indices were investigated through 
tubular differentiation index (TDI) and repopulation 
index (RI) and spermatogenesis index (SI). For measur-
ing TDI, SI and RI, one transverse section was taken 
from the center of one testis from each rat, and at least 
200 seminiferous tubule cross sections were scored in 
that section. The TDI is the percentage of seminiferous 
tubules that contained three or more differentiated lay-
ers of germinal cells derived from type A spermatogonia. 
To find out the RI, the ratio of active (type B) to inactive 
(type A) spermatogonia (Fig. 1) was recorded and SI was 
expressed as the ratio of the number of seminiferous 
tubules with spermatozoids to empty tubules.
The histometrical parameters including seminiferous 
tubules diameter (STsD), germinal epithelium height 
(GEH), testicular capsule diameter (TCD), seminiferous 
tubules lumen diameter (STsLD) and Tubular degenera-
tion percentage (TDP) were evaluated by microscopical 
examination of sections. The Histometrical studies were 
carried out using Dino-Lite lens digital camera and Dino-
capture 2 Software. The STsD, GEH, TCD, and STsLD 
were expressed as mean micrometer and the TDP was 
the percentage of degenerated tubules.
Statistical analysis
The statistical analyses were performed using SPSS soft-
ware version 22 (SPSS Inc., USA). The Shapiro–Wilk 
normality test was used to verify the normality of the 
data. Considering the normal distribution of the data, 
parametric tests were used. Differences among individual 
groups were determined by one-way ANOVA analysis 
followed by Tukey’s test for pair-wise comparisons. The 
values were expressed as the means ± standard devia-
tion (SD). A p value of < 0.05 was considered statistically 
significant.
Results
The results of epididymal sperm analysis from all studied 
groups have been summarized in Table 2.
Fig. 1 Type A spermatogonia (dotted arrow): inactive type with pale 
nuclei; Type B spermatogonia (arrow): the active type with dark nuclei
Table 2 Effects of different doses of HESS and glibenclamide on gonadal mass and sperm parameters
Testicular weight (TW), gonadosomatic indices (GSI), HESS (hydroalcoholic extract of S. securidaca seeds); G (glibenclamide); DC (diabetic control); NC (normal control)
a : statistically significant difference with NC group
b : statistically significant difference with DC group
Groups TW (g)
(single testis)
GSI (%) Total sperm count 
(×  107) /mLof HTF
Viability (%) Motility (%) DNA-damage (%) Abnormality (%) Maturity
NC 1.62 ± 0.09b 0.45 ± 0.05 99.40 ± 2.7 b 89.4 ± 3.6 b 87.8 ± 3.1 b 6.4 ± 1.8 b 11.6 ± 1.8 b 98.4 ± 1.5 b
DC 1.33 ± 0.05a 0.55 ± 0.09 48.60 ± 3.5 a 47.8 ± 5.8 a 54.0 ± 6.0 a 34.2 ± 2.6 a 38.0 ± 3.4 a 84.8 ± 0.5 a
HESS‑100 1.44 ± 0.03a 0.53 ± 0.04 50.40 ± 3.6 a 58.4 ± 2.9 a 56.6 ± 6.6 a 30.4 ± 1.1 a 34.0 ± 4.5 a 86.4 ± 2.1 a
HESS‑200 1.47 ± 0.07 0.52 ± 0.06 57.80 ± 4.2 a 63.4 ± 4.0 a 60.8 ± 4.8 a 28.8 ± 1.6 a 30.4 ± 5.6 a 87.0 ± 1.2 a
HESS‑400 1.52 ± 0.1b 0.53 ± 0.01 60.50 ± 3.1 a 71.0 ± 2.9 a 63.0 ± 5.1 a 24.7 ± 1.3 a 28.0 ± 1.8 a 90.2 ± 1.7 a
G 1.54 ± 0.1b 0.57 ± 0.06 94.20 ± 2.4b 80.0 ± 3.8 b 79.2 ± 4.1 b 11.6 ± 2.4 b 17.2 ± 2.9 b 94.4 ± 2.7 b
G + HESS‑200 1.49 ± 0.04b 0.54 ± 0.06 96.80 ± 3.5 b 85.6 ± 4.8 b 82.4 ± 2.4 b 11.0 ± 2.7 b 13.0 ± 3.1 b 95.0 ± 1.6 b
G + HESS‑400 1.50 ± 0.05b 0.52 ± 0.06 98.80 ± 1.9 b 86.2 ± 4.3 b 85.4 ± 4.6 b 10.6 ± 2.9 b 11.8 ± 4.1 b 97.0 ± 2.7 b
P‑value 0.001 0.93 0.001 0.001 0.001 0.001 0.001 0.001
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The effects of treatments on TW
TW of untreated diabetic rats was significantly lower 
than those of healthy rats (P < 0.05) and the treatment 
with HESS and glibenclamide increased the weight back 
so that the difference was statistically significant at the 
highest dose of HESS and glibenclamide (P < 0.05). In 
comparison with single-agent therapy, the combination 
therapy of HESS and glibenclamide did not cause more 
TW gain (P > 0.05). One-way ANOVA did not show any 
significant differences in GSI between the experimental 
and control groups (P > 0.05).
Effects of treatments on sperm parameters
As shown in Table  2, the average sperm count and the 
percentage of mature spermatozoa (Fig. 2-A), as well as 
sperm motility, and viability (Fig. 2-B) were significantly 
reduced in diabetic rats compared to healthy control 
group (P < 0.05). HESS improved the sperm parameters 
dose-dependently in diabetic rats, which were significant 
at doses of 400 mg/kg B.W. (P < 0.01). Compared with the 
highest amount of HESS, glibenclamide more effectively 
(P < 0.01) improved the parameters to the levels detected 
in the healthy control group (P > 0.05). Combination ther-
apy with the HESS partly enhanced the effects of gliben-
clamide, so that the sperm count, maturity, motility, and 
viability in the G + HESS-400 group were similar to those 
in healthy rats.
The percentages of DNA damage and sperm abnormal-
ity were determined by Acridine-Orange (Fig.  2-C) and 
Eosin-Nigrosine (Fig.  2-D) staining, respectively. Com-
pared to the healthy control, both DNA damage and 
sperm abnormality were significantly higher in diabetic 
rats (P < 0.05). HESS treatment reduced both defects in 
a dose-dependent manner in the diabetic rats (P < 0.05), 
but glibenclamide was more effective than the high-
est dose of HESS in this regard (P < 0.05). Combination 
therapy with HESS increased the effects of glibencla-
mide so that the values were close to those in healthy rats 
(P > 0.05).
Effects of HESS and glibenclamide on testicular histology
As shown in Fig. 3-A, the histopathological examination 
of testes of the NC group showed normal structure of 
the seminiferous tubules with typical consecutive stages 
of spermatogenesis, without abnormal changes in ger-
minal epithelium and interstitial connective tissue. The 
hexagonal or rounded seminiferous tubules are separated 
with a thin intertubular interstitial connective tissue, 
and contain normal spermatogenic epithelium. On the 
contrary, the DC, HESS-100, HESS-200, and HESS-400 
Fig. 2 Photomicrographs of spermatozoa stained with specific methods for different purposes. A) Aniline blue for differentiation of immature (a, 
with a blue stained head) and mature (b, unstained) sperms. B) Eosin‑Y‑0.05% that distinguishes live sperms with uncolored heads (a) from dead 
ones with red‑stained heads (b). C) Acridine‑Orange, which differentiates sperms with intact chromatin structure (a, with a green fluorescence 
illuminating head) from those with denatured chromatin (b with a reddish‑orange head. D) Eosin‑Nigrosine for detection of sperms with 
morphological abnormalities
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groups (Figs.  3-B-E) showed degenerative changes 
including testicular atrophy, shrunken tubules, hypocel-
lularity, rupture, and vacuolation of the seminiferous 
tubular epitheliumand incomplete spermatogenesis. The 
spermatogenesis indices and histometrical parameters 
(Tables 3 and 4) were significantly deteriorated compared 
with the NC group. Figures  3-B-E demonstrate expan-
sion of interstitial tissue and shrinkage of seminiferous 
tubuleslong with depletion of germ cells. Interestingly, 
all aforementioned changes in tissue characteristics of G, 
Fig. 3 Morphological assessment of testicular tissue. A) Normal control group with typical seminiferous tubules showing the consecutive 
stages of spermatogenesis. B) Diabetic control group, C) HESS‑100 group, D) HESS‑200 group and E) HESS‑400 group with tissue atrophy and 
degenerative changes in the seminiferous tubules including shrinkage, hypocellularity, vacuolation and rupture of the epithelium, and disrupted 
spermatogenesis. F) G (glibenclamide) group, G) G + HESS‑200 group and H) G + HESS‑400 group with mild histomorphological changes compared 
to the NC group
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G + HESS-200 and G + HESS-400 groups (Figs.  3G-H), 
as well as the spermatogenesis indices and histometrical 
parameters (Tables 3 and 4) were negligible, close to the 
NC group.
Effects of HESS and glibenclamide on biochemical 
parameters
In this study, one-way ANOVA showed a significant dif-
ference in the measured biochemical parameters between 
the experimental and control groups (Table 5).
Compared with the NC group, a significant decrease 
in serum insulin and TS levels was observed in the DC 
group (P < 0.001). Serum insulin levels were increased 
significantly and dose-dependently in the HESS-treated 
groups compared to DC group (P < 0.05). In this regard, 
Table 3 Spermatogenesis indices in the study groups
TDI (Tubular Differentiation Index), SI (Spermatogenesis Index) and RI 
(Repopulation Index)
a : statistically significant difference with NC group
b : statistically significant difference with DC group
Groups TDI (%) SI (%) RI (%)
NC 90.7 ± 2.5 b 94.1 ± 3.0 b 94 ± 2.6 b
DC 60.9 ± 3.3 a 49.9 ± 3.3 a 55 ± 2.7 a
HESS‑100 64 ± 3.2 a 51.1 ± 2.7 a 58.2 ± 1.4 a
HESS‑200 68.4 ± 1.7 a 57.2 ± 2.5 a 59.3 ± 1.5 a
HESS‑400 72.8 ± 2.5 b 62.9 ± 2.7 b 63.7 ± 3.0 b
G 81.4 ± 3.0 b 78.9 ± 2.1 b 82.6 ± 4.5 b
G + HESS‑200 88 ± 2.1 b 88.8 ± 3.1 b 89 ± 1.8 b
G + HESS‑400 89.2 ± 2.2 b 90.4 ± 1.8 b 89.5 ± 2.7 b
P‑value  < 0.001  < 0.001  < 0.001
Table 4 Histometrical parameters in the study groups
STsD (seminiferous tubules diameter), GEH (germinal epithelium height), TCD (testicular capsule diameter), STsLD (seminiferous tubules lumen diameter), TDP 
(Tubular Degeneration percentage)
a : statistically significant difference with NC group
b : statistically significant difference with DC group
Groups STsD (µm) GEH (µm) TCD (µm) STsLD (µm) TDP (%)
NC 375.53 ± 17.8 b 131.66 ± 13.5 b 20.4 ± 2.44 b 93.39 ± 6.27 b 5.6 ± 1.14 b
DC 204.99 ± 12.3 a 85.17 ± 4.7 a 39.94 ± 2.77 a 67.49 ± 5.73 a 16.2 ± 3.27 a
HESS‑100 210.91 ± 14.6 a 87.75 ± 4.7 a 39.72 ± 2.92 a 68.92 ± 6.14 a 15.8 ± 2.39 a
HESS‑200 218.73 ± 13.6 a 89.44 ± 2.7 a 36.89 ± 3.59 a 68.115 ± 5.49 a 15.6 ± 4.22 a
HESS‑400 230.1 ± 9.4 a 95.9 ± 4.7 a 37.91 ± 2.51 a 69.6 ± 3.66 a 15.6 ± 3.91 a
G 319.66 ± 39.3 b 122.26 ± 7.7 b 26.82 ± 3.17 b 84.17 ± 5.83 b 8.4 ± 2.41 b
G + HESS‑200 339.22 ± 27.3 b 127.72 ± 6.6 b 22.46 ± 3.15 b 87.52 ± 7.23 b 7.6 ± 2.97 b
G + HESS‑400 356.26 ± 25.25 b 129.63 ± 7.43 b 22.22 ± 4.61 b 89.67 ± 4.28 b 6.8 ± 4.32 b
P‑value  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001
Table 5 Biochemical parameters of studied groups
TS (Testosterone), LDH (lactate dehydrogenase), FRAP (ferric reducing antioxidant power)
a : statistically significant difference with NC group













NC 0.098 ± 0.008b 3.80 ± 0.2b 187.1 ± 8.5b 0.47 ± 0.01b 8.66 ± 0.35b 1.97 ± 0.15b
DC 0.079 ± 0.001a 2.62 ± 0.29a 171.9 ± 1.4a 0.34 ± 0.02a 6.55 ± 0.34a 1.18 ± 0.09a
HESS‑100 0.079 ± 0.001a 2.78 ± 0.14a 174.7 ± 3.0a 0.36 ± 0.02a 6.50 ± 0.36a 1.4 ± 0.05a,b
HESS‑200 0.081 ± 0.004a 2.90 ± 0.24a 176.9 ± 2.9a 0.37 ± 0.01a 6.64 ± 0.37a 1.54 ± 0.07a,b
HESS‑400 0.090 ± 0.003b 3.24 ± 0.1a,b 179.5 ± 1.3b 0.41 ± 0.08a,b 7.05 ± 0.12a 1.56 ± 0.09a,b
G 0.096 ± 0.003b 3.36 ± 0.23b 181.4 ± 2.2b 0.44 ± 0.02b 7.64 ± 0.28a,b 1.75 ± 0.07a,b
G + HESS‑200 0.096 ± 0.001b 3.39 ± 0.16b 182.8 ± 1.1b 0.43 ± 0.02b 7.63 ± 0.41a,b 1.80 ± 0.09b
G + HESS‑400 0.100 ± 0.006b 3.63 ± 0.31b 184.1 ± 1.0b 0.44 ± 0.02b 7.70 ± 0.33a,b 1.82 ± 0.09b
P‑value  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001
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glibenclamide was more effective than the highest dose 
of HESS and its combination with HESS restored insu-
lin to the comparable levels in healthy rats (P > 0.05). 
The highest dose of HESS (400 mg/kg-BW) significantly 
increased the serum concentrations of TS in diabetic 
rats (P = 0.013), however, glibenclamide was more 
effective in this regard. Co-administration of glibencla-
mide with HESS increased the serum TS to equivalent 
levels in the NC group (P > 0.05).
As expected, the lower FRAP levels were observed in 
testicular tissue of diabetic control compared to healthy 
rats (P < 0.05). HESS administration, even at the high-
est dose, slightly increased antioxidant capacity in dia-
betic rats. Glibenclamide could increase FRAP level in 
diabetic rats (P < 0.05), but still at a lower level than the 
healthy rats (P > 0.05). Co-administration of glibencla-
mide with HESS did not improve the effects of standard 
drug. Regression analysis of TS on FRAP adjusted for 
groups and revealed a positive association (B = 0.009, 
P = 0.001).
Compared to the NC group, lower levels of glycogen, 
lactate, and LDH activity were detected in the testicu-
lar tissue of the DC group (P < 0.001). Administration of 
various doses of HESS slightly increased tissue levels of 
these parameters in diabetic rats, but the elevated lev-
els became statistically significant at the highest dose of 
HESS (P < 0.05). Glibenclamide was slightly more effec-
tive than the highest dose of HESS, so that levels of gly-
cogen, lactate, and LDH activity were close to those in 
the healthy group (P > 0.05). Co-administration of glib-




Based on Figs.  4-A and 4-B, the LDH gene expression 
level in testicular tissue of healthy rats was significantly 
higher than that in diabetic rats (P < 0.05). HESS therapy 
increased the expression of the LDH gene in diabetic 
rats that were dose-dependent (P < 0.05). Glibenclamide 
was not effective in stimulating LDH expression and 
the increased values in G + E200 and G + E400 groups 
(P < 0.05) can be attributed to HESS as supplement.
FGF21
According to Figs. 5-A and -B, compared to the healthy 
group, a mild increase in FGF21 gene expression was 
obseved in the testicular tissue of diabetic rats (P > 0.05). 
Treatment with HESS increased FGF21 gene expres-
sion levels dose dependantly which was significant at the 
highest dose of HESS compared with diabetic control 
(P < 0.05). In this regard, glibenclamide was slightly more 
effective than the highest dose of HESS (P > 0.05), and its 
combinational therapy with both doses of HESS (200 and 
400 mg/kg.BW) did not significantly changed the FGF21 
gene expression (P > 0.05).
Regression analysis of testicular FGF21 gene expres-
sion adjusted for FRAP revealed a positive but not sig-
nificant effect of FGF-21 gene expression levels on FRAP 
(B = 0.02, P = 0.2).
Discussion
In a previous series of studies, we examined the effects 
of S. securidaca, glibenclamide, and a combination of 
both on diabetes complications. Our previous results 
demonstrated the antihyperglycemic, antioxidant and 
Fig. 4 LDH gene expression levels (A), and comparison of fold changes (B) in the testicular tissue in different groups
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antiatherogenic properties of the herbal extract, which 
were enhanced when combined with glibenclamide as 
a classical drug [24, 25]. In the current study, the side 
effects of S. securidaca on testicular tissue and sperm 
parameters in male diabetic rats were investigated and 
compared with the results of glibenclamide alone and in 
combination.
The testicular changes in diabetic animals are consist-
ent with previous reports showing the negative effects 
of diabetes on intertubular tissue and fertility indices in 
male animals [36, 37]. The main destructive mechanisms 
proposed in these studies are the activation of several 
cellular signalling pathways by reactive oxygen species 
(ROS), such as the accelerated formation of AGE, the 
hexosamine pathway, and the polyol pathway [38, 39]. 
Significant testicular weight loss was observed in the tes-
tes of diabetic rats compared to normal rats. Treatment 
with the highest dose of HESS as well as with glibencla-
mide and combination of both significantly increased the 
testicular weight of the diabetic rats. Despite the men-
tioned changes in testicular mass, GSI was the same in 
all experimental groups and even slightly decreased in 
the healthy control in comparison with other groups. 
GSI, a parameter for assessing reproductive output, has 
been reported to decrease in GSI in diabetic rats [40, 
41]. This discrepancy is explained by the fact that GSI 
is the ratio of gonad mass to the body mass, two factors 
that decrease in diabetes. Obviously, it is possible not to 
change the ratio of two numbers. Therefore, GSI parame-
ter does not seem to be an accurate indicator in diabetes.
Histological observations of the testes of healthy con-
trol rats revealed normal hexagonal or rounded seminif-
erous tubules separated by a thin intertubular interstitial 
tissue. The normal spermatogenic layers in the germinal 
epithelia contained primary and secondary spermato-
cytes, spermatids and spermatozoa. Diabetic rats showed 
testicular atrophy and degenerative changes in the sper-
matogenic layers, associated with impaired spermato-
genesis. The interstitial tissue was enlarged and the 
seminiferous tubules were shrunken and significantly 
depleted of germ cells. Thus, this study demonstrated 
hyperglycemia (glucotoxicity) effects on the induction 
of testicular tissue damage, which is due to the increased 
oxidative stress and cellular apoptosis in diabetes by 
increasing ROS production and inhibiting the antioxi-
dant defense system [42, 43]. Treatment with different 
doses of HESS did not improve degenerative changes in 
the seminiferous tubules, but a decrease in the interstitial 
tissue volume with a tendency to improve seminiferous 
tubular structure was observed in groups treated with 
the highest dose of HESS, and seminiferous tubules were 
closer together compared to the DC group.
The observed structural abnormalities in the testicu-
lar tissues of DC, HESS-100, HESS-200 and HESS-400 
groups were consistent with the estimated histometric 
parameters of STsD, GEH, TCD, STsLD and TDP. Com-
pared with healthy control, the seminiferous tubule, 
lumen diameters and germinal epithelium height were 
significantly decreased, while tubular degeneration and 
testicular capsule diameter were significantly increased 
in testicular tissue of DC group. Administration of differ-
ent doses of HESS improved histometric parameters in a 
partially dose-dependent manner; however, the changes 
were not statistically significant compared to the indi-
ces of the DC group. Compared with the highest admin-
istered dose of HESS, glibenclamide more effectively 
Fig. 5 FGF21 gene expression levels (A), and comparison of fold changes (B) in the testicular tissue in different groups
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ameliorated the pathological conditions observed in dia-
betic rats. In agreement with the findings of Chatterjee 
et al. (2013) on the effect of glibenclamide on diabetic tes-
tis [44], regular outlines in most of seminiferous tubules 
and narrow intertubular interstitial tissue were observed 
in the sections of G group. The combination of glibencla-
mide with HESS normalized testicular tubules to com-
parable levels in healthy rats. Tissue observations were 
consistent with histometric parameters, in which gliben-
clamide alone significantly increased seminiferous tubule 
and lumen diameters and germinal epithelium height, 
while it significantly decreased tubular degeneration and 
testicular capsule diameter compared with the HESS-400 
group. The combination with HESS partially enhanced 
the effects of glibenclamide on histometric parameters. 
Thus, glibenclamide alone was more protective than the 
highest dose of HESS in preventing testicular dysfunc-
tion, and the combination with HESS enhanced its effects 
to some extent. Similar to previous reports, diabetes had 
negative effects on sperm quality of rats in the group 
DC, such as a decrease in sperm count, motility, viabil-
ity, maturity, and an increase in sperm abnormalities and 
DNA damage compared to healthy rats [39, 44, 45].
Histopathological examination showed that a decrease 
in epididymal sperm count was associated with a reduc-
tion in the number of spermatogenic cell layers in semi-
niferous tubules and reduced indices of spermatogenesis 
and tubular differentiation. Also, decrease in epididymal 
sperm count was a result of increase in the number of 
inactive spermatogonia associated with the reduction 
of the repopulation index. HESS dose-dependently pre-
vented the occurrence of such sperm abnormalities in 
diabetic rats. Glibenclamide was more effective than the 
highest dose of HESS in this regard, and the combination 
with the highest dose of HESS improved the abnormali-
ties to the values close to the healthy control group. The 
higher doses of HESS considerably prevented a decrease 
in sperm count and to some extent increased sperm 
maturation, motility and viability in diabetic rats. How-
ever, glibenclamide alone was more effective than the 
highest dose of HESS in this regard, and concomitant 
administration with the highest dose of HESS raised the 
sperm count, motility, viability, and percentage of sperm 
maturation to levels approaching those of the healthy 
control group. HESS prevented both DNA damage and 
abnormalities in the spermatozoa, but the injuries were 
significantly different from those in the healthy rats. 
Compared to the highest dose of HESS, glibenclamide 
more effectively prevented DNA damage and abnormali-
ties in sperms, and the combination with HESS enhanced 
the effect of glibenclamide. Similar to the histometric 
indices, glibenclamide alone improved the spermato-
genesis indices more effectively than the highest dose 
of HESS, and the combination with HESS improved the 
parameters to the values close to the healthy group. In 
insulin deficiency, insulin-dependent GnRH secretion is 
reduced, leading to decreased plasma LH and FSH levels 
[46]. The more significant effect of FSH on Sertoli cells 
in the seminiferous tubules and the greater effect of LH 
on Leydig interstitial cells is due to the abundance of 
FSH-R and LH -R in these cells. Moreover, FSH is una-
ble to increase the number of germ cells in the absence 
of androgen [47]. Thus, impaired spermatogenesis and 
a significant decrease in serum testosterone levels are 
phenomena that occur in diabetes due to changes in 
serum LH and FSH levels. Although HESS significantly 
increased serum testosterone levels in diabetic rats in 
the present study, glibenclamide was more effective than 
the highest dose of HESS in this regard, and its combina-
tion with HESS normalized serum testosterone levels. In 
addition to hormonal action, oxidative stress, as a com-
mon phenomenon in diabetic tissue damage, interferes 
with the secretion of testosterone from Leydig cells [48]. 
Glibenclamide increased FRAP more effectively than 
HESS, which could be identified as another mechanism 
for the effectiveness of glibenclamide in improving tes-
tosterone levels in diabetic rats. Spermatogenesis is a 
continuous process with specific energetic requirements. 
As mentioned earlier, lactate produced in Sertoli cells is 
subsequently exported to germ cells to be used as a sub-
strate for ATP production in mitochondria. Thus, lactate 
as an energy source has a crucial role in developing germ 
cells in the spermatogenic process [49]. It has recently 
been reported that glucose metabolism and lactate pro-
duction are under tight hormonal control, especially by 
sex hormones and FSH through modulation of LDH-A, 
GLUT and MCT4 levels in Sertoli cells [50, 51]. Like pre-
vious studies [51, 52], this study also found a decrease 
in LDH gene expression and enzyme activity and, con-
sequently, decreased testicular lactate levels in diabetic 
rats. Such abnormalities in the diabetic codition cause 
Sertoli cells to utilise their glycogen stores via the gly-
cogenolysis pathway, which may also act as a regulator of 
germ cell survival during fluctuations in insulin and glu-
cose concentrations. The observed decrease in testicular 
glycogen storage in STZ-treated subjects was associated 
with a decrease in blood insulin levels. Insulin deficiency 
inhibits glycogen synthesis by activating glycogen syn-
thase kinase 3 (GSK-3), which inhibits glycogen synthase 
1 (GYS1) and maintains glycogen phosphorylase in its 
activated form [53]. In addition, glucose uptake and lac-
tate production by Sertoli cells are subject to hormonal 
regulation. Hormone receptors located in Sertoli cells are 
sensitive to extracellular glucose levels. Reduction in the 
concentration of these receptors during hyperglycemia 
leads to downregulation of LDH, GLUT and MCT4 in 
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Sertoli cells [54]. Thus, glucose uptake, lactate production 
and its release and transport to germ cells are reduced 
in uncontrolled diabetes. Administration of HESS dose-
dependently increased both LDH gene expression and 
enzymatic activity as well as lactate concentration in tes-
ticular tissue of diabetic rats. Although glibenclamide was 
ineffective in altering the level of LDH gene expression, it 
increased both LDH enzymatic activity and lactate pro-
duction more effectively than the highest dose of HESS. 
The effect of glibenclamide on increasing LDH activity 
was comparable to the study by Ebokaiwe et al. [55], but 
we did not find studies that simultaneously assessed LDH 
gene expression. This discrepancy may be attributed to 
the possible post-transcriptional role of glibenclamide in 
mRNA stability, however it requires further investigation. 
A significant reduction in protein kinase B (AKT) phos-
phorylation due to insulin deficiency causes a decrease 
in glycogen synthase kinase-3 (GSK-3) phosphoryla-
tion and consequently an increase in glycogen synthase 
phosphorylation and inactivation [56]. As observed in 
this study, STZ-diabetic rats with lower blood insulin 
levels had lower testicular glycogen stores than healthy 
rats. The highest dose of HESS effectively increased gly-
cogen stores in diabetic rats, which was partially similar 
to the effect of glibenclamide in this regard. Following an 
increase in blood insulin levels in the groups treated with 
HESS, glibenclamide, and a combination of both, testicu-
lar glycogen storage also increased. It is noteworthy that 
STZ at low doses (≤ 50–55) leads to incomplete destruc-
tion of pancreatic β-cells according to the previous 
studies [24, 57]. Treatment with higher doses of HESS, 
glibenclamide, or a combination of both may result in 
partial regeneration or repair of pancreatic β cells and 
insulin re-secretion from surviving β cells.
Metabolic abnormalities in diabetes increase the pro-
duction of reactive oxygen/nitrogen species associated 
with diabetes-induced germ cell apoptosis. Nuclear fac-
tor 2 (Nrf2) is an important transcription factor that 
regulates the transcription of genes that have the anti-
oxidant response element (ARE) in their promoters and 
encode antioxidant factors such as FGF21 [58, 59]. As 
mentioned before, FGF21 is a multifunctional factor 
produced mainly in the liver. Accordingly, it is also pro-
duced in other organs and its production is stimulated 
in diabetes and oxidative conditions. FGF21 maintains 
the homeostasis of spermatogenesis and normal germ 
cell apoptosis by inhibiting the activation of p53 via 
MDM2 through AKT [21]. The present study showed 
that FGF21 gene expression was higher in diabetic rats 
than in healthy rats, although the mean difference was 
not statistically significant. The highest dose of HESS 
significantly increased FGF21 gene expression in dia-
betic rats. Glibenclamide was slightly more effective 
than the highest dose of HESS in this regard, and its 
combination with HESS did not significantly change 
FGF21 gene expression. Basically, there are two main 
factors, oxidative stress and hyperglycemia, that stimu-
late FGF21 gene expression in diabetes. The previous 
studies [24, 25] indicated that the highest dose of HESS 
and more effectivly glibenclamid decreased blood sugar 
and insulin resistance, and the combination of both 
normalized blood sugar comparable to the healthy 
control group. Moreover, due to richness of HESS in 
flavonoids and phenolic compounds as natural antioxi-
dants, the herbal extract was able to reduce oxidative/
nitrous stress and inflammation, and slightly increased 
total body antioxidant capacity in a dose dependent 
manner [24, 25]. Morover, the highest dose of HESS 
slightly increased the antioxidant capacity (FRAP) of 
testicular tissue, glibenclamide was slightly more effec-
tive in this regard, but the combination of both did not 
significantly change the tissue antioxidant capacity. 
Here, there is a contradiction; in spite of a decrease in 
blood sugar, as well as oxidative stress [24] and slightly 
increase in tissue FRAP, the FGF21 gene expression lev-
els significantly increased in testicular tissue of groups 
treated by HESS and glibenclamid. In other words, 
since FGF21 has been accepted as the main regulator 
of cell response to oxidative stress, a slight increase 
in tissue FRAP levels was observed despite increased 
FGF gene expression after treatment with HESS and 
glibenclamide. To justify this discrepancy through the 
results of previous studies, no research were found on 
the effect of glibenclamide as well as phenol-flavonoid 
compounds on FGF21 expression, and the interpreta-
tion of these results requires further research on molec-
ular causes and cellular signaling. Jiang et  al. reported 
that FGF21 deficiency disrupts the AKT/GSK-3/ GS 
and AMPK/Sirt1/PGC-1 signaling pathways in diabetic 
testes. This may lead to the accumulation of metabolic 
mediators that cause testicular oxidative damage and 
cell apoptosis [21]. They also showed that testicular 
oxidative stress was attenuated by FGF21 treatment. 
In another study, they reported that FGF21 deficiency 
activated the p53 testis in both diabetic and non-dia-
betic patients, which increased germ cell apoptosis [20]. 
Diabetes significantly inhibits testicular AKT activation 
and AKT-mediated glucose metabolism, which leads 
to impaired glucose metabolism and testicular oxida-
tive stress. AKT regulates cell survival by modulating 
the activity of several apoptotic and survival proteins, 
including p53 [20, 60]. FGF21 increases AKT1 activa-
tion, down-regulates p53, causes a decrease in germ 
cell apoptosis [20]. FGF21 also modulates the metabo-
lism of fatty acids to prevent the accumulation of their 
metabolic mediators, which cause oxidative stress in 
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the testes [61]. In the present study, the positive effects 
of the highest dose of HESS and the stronger effects of 
glibenclamide on testicular tissue healing may be partly 
attributed to the increased tissue expression of FGF21. 
However, diabetes cannot be totally managed by a sin-
gle or a number chemicals but by multiple chemicals 
and factors. Although restoration of serum insulin to 
the levels near normal values might be one of factors 
to compensate deleterious effects of diabetes, however 
the resone for high levels of FGF21 relation to pheno-
lics and flavonoids as well as glibenclamid needs furder 
examination. Although the decrease in serum insulin 
to the levels near normal values might be one of the 
factors to compensate deleterious effects of diabetes, 
however, the reason for high levels of FGF21 relation to 
phenolics and flavonoids as well as glibenclamide needs 
furder examination.
Conclusions
In a massive effort, researchers are combining standard 
drugs with botanicals to improve the drug’s effect on dia-
betes and reduce disease complications such as reduced 
sperm quality and male infertility. This study showed that 
S. securidaca seeds had no side effects on testicular tissue 
and sperm parameters and increased sperm quality and 
tissue status in diabetic male rats. However glibencla-
mide was more effective than such a medicinal plant, its 
combination with the highest dose of HESS enhanced its 
effectiveness comparable to non-diabetics. It also facili-
tated to maintain the quality of sperm parameters, tes-
ticular tissue and energy homeostasis. It is concluded, S. 
Securidaca seed can be considered as an effective supple-
ment in combination with hypoglycemic drugs to prevent 
reduced fertility in diabetic men.
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